Date: February 7-10, 2022.
Booth: 835
How can you accelerate your clinical research?
Developing new medicines is risky: it takes a whole lot of time and money, with no guarantee of success.
Find new ways to improve efficiency, increase effectiveness and accelerate the process to generate cost savings in drug development and in time-to-market with Clinerion's Patient Network Explorer technology and global real-world data network, at SCOPE!
Clinerion will be out in full force at SCOPE 2022 – look out for us at our booth, no. 835!
Our colleagues will be available for discussions on how our real-world data, covering almost 250 million patients in 19 countries, can support your clinical research, whether through study feasibility, analysing cohorts, or matching eligible patients to trials.
(We apologize if you received an error message when submitting a meeting request via our webpage form, before. Please use the link above to contact us directly.)
The Clinerion Team at SCOPE 2022
|
Dr. Barış Erdoğan
CEO
Barış Erdoğan studied computer engineering and holds an M.Sc. and Ph.D. in educational technology. He practiced data mining techniques in various sectors including healthcare. He lectures on the topics of software development, database management, medical informatics, and project management. His expertise and experience include the management of innovative Medical Informatics projects and implementation of end-to-end Healthcare IT enterprise information systems, both in the public and private sectors
|
|
Douglas Drake, MS, MBA
Senior Director, Customer Solutions
Douglas is originally a life science researcher with a passion for digital enablement of better patient care. For over 30 years, Douglas has worked in various aspects of diagnostics, therapeutic research, drug discovery and global business development. He has broad experience in transformative technologies, data sciences, digital healthcare and applying these to improving patient engagement and the patient journey.
|
|
Daniel Gutierrez, PhD
Customer Solutions Director
Daniel is a physicist and cardiac physiologist by training, educated at the Colombia Universidad del Valle as well as at the EPFL(Lausanne), University of Bern, and ETH Zurich. At the latter, he expanded his knowledge in biomedical engineering and molecular imaging applied to pre-clinical drug development in the field of oncology. Daniel additionally applied and furthered his experience in immuno-oncology and therapeutic antibodies while working at Roche where he was key in the development of techniques to visualize and understand the mode of action mechanisms of antibodies when killing tumours. Later, Daniel founded his own company, GeneLook AG, where he developed and implemented a digital health solution in the field of genetics to remotely pre-screen and validate rare disease patients that were potentially enrollable in clinical trials.
|
|
Diana Aghekyan
Customer & Site Network Solutions Consultant
Diana has a strong international background, holds a bachelor's degree from a Greek University and is furthering her studies related to the clinical operations setting. With a working experience within healthcare since 2016, at Clinerion she manages customer/partner projects, maintains hospital relations, as well as consults activities in the field of Site and Patient Identification and EHR Data.
|